and Hypertension specializes in the diagnosis and treatment of patients with kidney diseases and arterial hypertension. Our research activities are carried out within several independent research groups

induced pluripotent stem cell-derived endothelial cells as in vitro disease model for pulmonary arterial hypertension" Sanja Sladic (RG Hilfiker): "Investigation of different cell sources in role of mural

pulmonary hypertension (PH). There are many forms of this disease. One of them is idiopathic pulmonary arterial hypertension (IPAH). This is a rare but very severe form of pulmonary hypertension. The term "i [...] annover.de , telephone (0511) 532-3537. The original paper "Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis" can be found here: https://www.thelancet.com/journals/lanres

pressure (arterial hypertension) Pulmonary hypertension (high pressure in the lungs) Rhythm disturbances Clarification of syncope Congenital or acquired vascular constrictions (stenoses) in arteries (e.g.

(examination spectrum: abdomen, lymph nodes, emergency examinations (FAST), vascular structures (arterial and venous) Carrying out sonography-assisted punctures Communication/demonstration of findings to

surgery and post-operative care Heart failure, medication and implantation of artificial hearts Arterial hypertension ("high blood pressure") Pulmonary hypertension ("high lung pressure"), entire spectrum

operations may have to be performed. These include pulmonary artery banding (PAB): This involves placing a belt-shaped loop around the pulmonary artery - with the aim of restricting blood flow into the lungs

neurovascular diseases. These include stenoses or tears (dissections) of the cervical or cerebral arteries, thromboses of the cerebral veins and malformations of the cerebral vessels. As part of the consultation

congenic rat strain SHRSP.WKY-Ace", description of a potential candidate gene for the development of arterial hypertension). Dr. Junge is a member of the Society for Pediatric Cardiology (GPK), the German Society

Activation of the metabolic master regulator PPARgamma - A potential PIOneering therapy for pulmonary arterial hypertension. Am J Respir Cell Mol Biol. 2019. https://www.ncbi.nlm.nih.gov/pubmed/31577451 Sallmon [...] Hansmann G. Emphysema is-at the most-only a mild phenotype in the Sugen/Hypoxia rat model of pulmonary arterial hypertension. Am J Respir Crit Care Med. 2019;200:1447-1450. https://www.ncbi.nlm.nih.gov/pubme [...] Chouvarine P, Legchenko E, Kokeny G, Mozes MM, Hansmann G. Chronic TGF-beta1 signaling in pulmonary arterial hypertension induces sustained canonical Smad3 pathways in vascular smooth muscle cells. Am J Respir